- Home
- VEON vs NAMS Comparison
VEON vs NAMS Comparison
Compare VEON & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEON
- NAMS
- Stock Information
- Founded
- VEON 1992
- NAMS 2019
- Country
- VEON Netherlands
- NAMS Netherlands
- Employees
- VEON N/A
- NAMS N/A
- Industry
- VEON Telecommunications Equipment
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- VEON Telecommunications
- NAMS Health Care
- Exchange
- VEON Nasdaq
- NAMS Nasdaq
- Market Cap
- VEON 2.3B
- NAMS 2.3B
- IPO Year
- VEON 1996
- NAMS N/A
- Fundamental
- Price
- VEON $33.05
- NAMS $24.90
- Analyst Decision
- VEON Strong Buy
- NAMS Strong Buy
- Analyst Count
- VEON 1
- NAMS 6
- Target Price
- VEON $48.00
- NAMS $33.80
- AVG Volume (30 Days)
- VEON 37.5K
- NAMS 419.7K
- Earning Date
- VEON 11-14-2024
- NAMS 11-06-2024
- Dividend Yield
- VEON N/A
- NAMS N/A
- EPS Growth
- VEON N/A
- NAMS N/A
- EPS
- VEON N/A
- NAMS N/A
- Revenue
- VEON $3,867,000,000.00
- NAMS $33,594,000.00
- Revenue This Year
- VEON $11.98
- NAMS N/A
- Revenue Next Year
- VEON $7.27
- NAMS N/A
- P/E Ratio
- VEON $7.58
- NAMS N/A
- Revenue Growth
- VEON 6.53
- NAMS 78.77
- 52 Week Low
- VEON $18.50
- NAMS $8.90
- 52 Week High
- VEON $34.00
- NAMS $26.35
- Technical
- Relative Strength Index (RSI)
- VEON 58.51
- NAMS 78.93
- Support Level
- VEON $30.94
- NAMS $24.23
- Resistance Level
- VEON $33.99
- NAMS $19.30
- Average True Range (ATR)
- VEON 1.10
- NAMS 1.27
- MACD
- VEON 0.11
- NAMS 0.52
- Stochastic Oscillator
- VEON 77.38
- NAMS 96.99
About VEON VEON Ltd. ADS
VEON Ltd is a global provider of connectivity and internet services. The company provides its customers with voice, fixed broadband, data, and digital services. Currently, the company offers services to customers in the following countries: Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. The reportable segments currently consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. The company provides services under the Beeline, Kyivstar, banglalink and Jazz brands.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.